| Phosphorylated tau interactome in the human Alzheimer’s disease brain E Drummond, G Pires, C MacMurray, M Askenazi, S Nayak, M Bourdon, ... Brain 143 (9), 2803-2817, 2020 | 266 | 2020 |
| Proteomic differences in amyloid plaques in rapidly progressive and sporadic Alzheimer’s disease E Drummond, S Nayak, A Faustin, G Pires, RA Hickman, M Askenazi, ... Acta neuropathologica 133, 933-954, 2017 | 231 | 2017 |
| The amyloid plaque proteome in early onset Alzheimer’s disease and Down syndrome E Drummond, T Kavanagh, G Pires, M Marta-Ariza, E Kanshin, S Nayak, ... Acta neuropathologica communications 10 (1), 53, 2022 | 102 | 2022 |
| Compilation of reported protein changes in the brain in Alzheimer’s disease M Askenazi, T Kavanagh, G Pires, B Ueberheide, T Wisniewski, ... Nature Communications 14 (1), 4466, 2023 | 72 | 2023 |
| Isolation of amyloid plaques and neurofibrillary tangles from archived Alzheimer’s disease tissue using laser-capture microdissection for downstream proteomics E Drummond, S Nayak, G Pires, B Ueberheide, T Wisniewski Laser Capture Microdissection: Methods and Protocols, 319-334, 2018 | 52 | 2018 |
| Proteomic differences in the hippocampus and cortex of epilepsy brain tissue G Pires, D Leitner, E Drummond, E Kanshin, S Nayak, M Askenazi, ... Brain Communications 3 (2), fcab021, 2021 | 49 | 2021 |
| Epigenetic silencing of the ubiquitin ligase subunit FBXL7 impairs c-SRC degradation and promotes epithelial-to-mesenchymal transition and metastasis L Moro, D Simoneschi, E Kurz, AA Arbini, S Jang, N Guaragnella, ... Nature cell biology 22 (9), 1130-1142, 2020 | 41 | 2020 |
| Secernin-1 is a novel phosphorylated tau binding protein that accumulates in Alzheimer’s disease and not in other tauopathies G Pires, S McElligott, S Drusinsky, G Halliday, MC Potier, T Wisniewski, ... Acta Neuropathologica Communications 7, 1-17, 2019 | 33 | 2019 |
| Proteomics and transcriptomics of the hippocampus and cortex in SUDEP and high-risk SUDEP patients DF Leitner, JD Mills, G Pires, A Faustin, E Drummond, E Kanshin, ... Neurology 96 (21), e2639-e2652, 2021 | 31 | 2021 |
| Similar brain proteomic signatures in Alzheimer’s disease and epilepsy D Leitner, G Pires, T Kavanagh, E Kanshin, M Askenazi, B Ueberheide, ... Acta Neuropathologica 147 (1), 27, 2024 | 16 | 2024 |
| CBP-HSF2 structural and functional interplay in Rubinstein-Taybi neurodevelopmental disorder A de Thonel, JK Ahlskog, K Daupin, V Dubreuil, J Berthelet, C Chaput, ... Nature communications 13 (1), 7002, 2022 | 11 | 2022 |
| Proteomic differences in the hippocampus and cortex of epilepsy brain tissue. Brain Commun 3: fcab21 G Pires, D Leitner, E Drummond, E Kanshin, S Nayak, M Askenazi, ... | 8 | 2021 |
| Use of Affinity Purification–Mass Spectrometry to Identify Phosphorylated Tau Interactors in Alzheimer’s Disease G Pires, B Ueberheide, T Wisniewski, E Drummond Alzheimer’s Disease: Methods and Protocols, 263-277, 2022 | 6 | 2022 |
| The influence of APOEε4 on the pTau interactome in sporadic Alzheimer’s disease M Thierry, J Ponce, M Martà-Ariza, M Askenazi, A Faustin, D Leitner, ... Acta Neuropathologica 147 (1), 91, 2024 | 5 | 2024 |
| Differences in the cerebral amyloid angiopathy proteome in Alzheimer’s disease and mild cognitive impairment D Leitner, T Kavanagh, E Kanshin, K Balcomb, G Pires, M Thierry, ... Acta Neuropathologica 148 (1), 9, 2024 | 3 | 2024 |
| Compilation of all known protein changes in the human Alzheimer’s disease brain M Askenazi, T Kavanagh, G Pires, B Ueberheide, T Wisniewski, ... bioRxiv, 2023.04. 13.536828, 2023 | 3 | 2023 |
| It takes more than tau to tangle: using proteomics to determine how phosphorylated tau mediates toxicity in neurodegenerative diseases G Pires, E Drummond Neural Regeneration Research 16 (11), 2211-2212, 2021 | 3 | 2021 |
| Proteomic similarities in Alzheimer’s disease and epilepsy brains highlight the important role of tau: Molecular and cell biology/endosomal‐lysosomal dysfunction G Pires, D Leitner, E Kanshin, M Askenazi, D Friedman, O Devinsky, ... Alzheimer's & Dementia 16, e046234, 2020 | 1 | 2020 |
| The amyloid plaque proteome in different subtypes of Alzheimer’s disease: Human neuropathology: AD neuropathology E Drummond, G Pires, E Kanshin, M Askenazi, B Ueberheide, ... Alzheimer's & Dementia 16, e044973, 2020 | 1 | 2020 |
| CBP/EP300-dependent acetylation and stabilization of HSF2 are compromised in the rare disorder, Rubinstein-Taybi syndrome A de Thonel, JK Ahlskog, R Abane, G Pires, V Dubreuil, J Berthelet, ... bioRxiv, 481457, 2018 | 1 | 2018 |
